Repligen (RGEN) Tops Q1 EPS by 4c, provides guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $166.83 --0%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $169 million versus the consensus estimate of $163.4 million.
GUIDANCE:
Repligen sees FY2025 EPS of $1.63-$1.72, versus the consensus of $1.71.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Bitmine reports 5.82 million ETH holdings, $11.4B total assets
- Bonk, Inc. posts $5.5M revenue in H1 2026, reports $7.88M net loss
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
